Big uptick seen in outbound pharma M&A

0
1736
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Shanghai Fosun Pharmaceutical (Group), a leading Chinese healthcare provider, will acquire an approximate 86% stake in Indian pharmaceutical company Gland Pharma for US$1.26 billion.

This is the largest overseas acquisition made by a Chinese pharmaceutical company, and also China’s largest takeover of an Indian company.

story_2_picAs of early July 2016, Chinese firms had announced more than US$3.9 billion in overseas acquisitions in the pharmaceutical, biotechnology and healthcare sectors, a 10-fold increase from the amount spent in all of 2012, according to Bloomberg data.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link